Yaser Mahfouz

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review.

CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 30, 2026

BIO26-034: Electronic PowerPlan Transforming Blinatumomab Treatment Into a Safe, and Efficient Workflow.

BIO26-034: Electronic PowerPlan Transforming Blinatumomab Treatment Into a Safe, and Efficient Workflow.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost.

QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

BIO26-041: Medical Bioinformatics-Enabled Reminders Improve Pre-Visit Lab Readiness in a Hematology Clinic: A PDSA Quality Improvement Project.

BIO26-041: Medical Bioinformatics-Enabled Reminders Improve Pre-Visit Lab Readiness in a Hematology Clinic: A PDSA Quality Improvement Project.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review.

CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost.

QIM26-286: Ambulatory Blinatumomab via Infusion Pump: A FMEA-Driven Quality Improvement to Reduce Bed Utilization and Elevate Patient/Staff Experience and Decrease Cost.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

BIO26-041: Medical Bioinformatics-Enabled Reminders Improve Pre-Visit Lab Readiness in a Hematology Clinic: A PDSA Quality Improvement Project.

BIO26-041: Medical Bioinformatics-Enabled Reminders Improve Pre-Visit Lab Readiness in a Hematology Clinic: A PDSA Quality Improvement Project.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

BIO26-034: Electronic PowerPlan Transforming Blinatumomab Treatment Into a Safe, and Efficient Workflow.

BIO26-034: Electronic PowerPlan Transforming Blinatumomab Treatment Into a Safe, and Efficient Workflow.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study.

Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study.

Journal: Clinical Medicine Insights. Oncology

Published: January 14, 2024

Showing 1-9 of 9

Last Updated: 09/26/2026